Clinical Trial Update: Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm [NA]

View source ↗

Summary

A clinical trial evaluating segmentectomy versus lobectomy for small lung adenocarcinoma (≤2 cm) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Lung Adenocarcinoma | NA | Status: RECRUITING